Data / Form D filings / IMMUNETICS, INC.
IMMUNETICS, INC.: Form D filings
IMMUNETICS, INC., a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC between 2012 and 2014. The latest, on March 10, 2014, reports $835,000 sold of a $3 million offering to 12 investors.
Find out what IMMUNETICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 27 DRYDOCK AVE., Boston, MA, 02210
- Phone
- (617) 896-9100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Massachusetts
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1056227
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2014 | New notice | $3,000,000 | $835,000 | $2,165,000 | 12 | Feb 26, 2014 | sec.gov |
| Aug 10, 2012 | New notice | $750,000 | $629,090 | $120,910 | 24 | Aug 7, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Houry Youssoufian | Executive Officer | |
| Lois Silverman | Director | |
| Andrew Levin | Executive Officer, Director | |
| Richard Pinkowitz | Executive Officer | |
| Ron Zwanziger | Director | |
| John Yonkin | Executive Officer, Director | |
| Stephen Chubb | Director | |
| Richard Gibbs | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of Mar 10, 2014 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IMMUNETICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.